Avant Bio Fund II LP
01/03/2024 | Press release | Archived content
Ole Henrik Bang-Andreasen joins AVANT BIO as an Investment Analyst
Ole Henrik Bang-Andreasen joins AVANT BIO as an Investment Analyst having helped lead public investments in life sciences tools and technologies, diagnostics, medical devices, and other non-healthcare verticals at an investment firm. He started his career as an investor, with later roles as a sell-side analyst and a long/short healthcare investment analyst. At AVANT BIO he plays a role in investment research and strategy, thesis development, and European relations.
Ole earned his Bachelor of Science in Accounting and Finance at Northeastern University, and his Master of Science in Econometrics at Boston University and has held roles both in the US and Europe.
Avant Bio Fund II LP published this content on January 03, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 30, 2026 at 03:50 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]